Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007
Completed
- Conditions
- Infections, Rotavirus
- Interventions
- Other: Data collection
- Registration Number
- NCT01563146
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
This study aims to collect data and assess the number of rotavirus related hospitalizations in 11 hospitals in Belgium - season 2006-2007 in order to develop proper age-cohort analysis over time.
- Detailed Description
This retrospective study will use anonymised data, extracted from hospital databases during the period of the 1st of June 2006 until the 31st of May 2007. IMS Health sales data will be used to provide rotavirus vaccine coverage estimates (Rotarix and Rotateq) for the Belgian population during the study period. Any additional source of vaccine coverage status describing rotavirus vaccine uptake in the study population will also be reported.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
- Child aged ≤5 years;
- A stool sample has been provided for a rotavirus detection test during the study period;
- Laboratory test result of rotavirus is available.
Exclusion Criteria
Not applicable.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group A Data collection All children ≤ 5 years old with a rotavirus detection test (inpatient and ambulatory tests) performed during the period of June the 1st 2006 and May the 31st 2007.
- Primary Outcome Measures
Name Time Method Determination of the absolute number of rotavirus related hospitalisations in children up to five years old. From June 1st 2006 up to 1 year
- Secondary Outcome Measures
Name Time Method Classification of patients with rotavirus hospitalisation by birth cohorts, gender, time of the event, vaccine coverage status. From June 1st 2006 up to 1 year Evaluation of the herd effect. From June 1st 2006 up to 1 year Determination of the duration of rota-related hospitalisation for community acquired and nosocomial infection per birth cohort. From June 1st 2006 up to 1 year